| Name
|
Size
|
Creator |
Creation Date
|
Last Modification Date
|
Labels |
Attached To |
|
Microsoft Excel Spreadsheet Breast_Radiologist_Density_Assessments.xlsx |
11 kB |
Tracy Nolan |
Jun 13, 2022 14:49 |
Jun 13, 2022 14:49 |
|
Page: Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)
|
|
File train_ids.csv |
1 kB |
Tracy Nolan |
Jun 13, 2022 14:49 |
Jun 13, 2022 14:49 |
|
Page: Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)
|
|
File test_ids.csv |
0.4 kB |
Tracy Nolan |
Jun 13, 2022 14:49 |
Jun 13, 2022 14:49 |
|
Page: Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)
|
|
File segmentation_filepath_mapping.csv |
128 kB |
Tracy Nolan |
Jun 13, 2022 14:49 |
Jun 13, 2022 14:49 |
|
Page: Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)
|
|
File Duke-Breast-Cancer-MRI_v2_20220609.tcia |
321 kB |
Tracy Nolan |
Jun 13, 2022 14:49 |
Jun 13, 2022 14:49 |
|
Page: Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)
|
|
File BreastAndFGT_MRI_SEG_only_20220609.tcia |
8 kB |
Tracy Nolan |
Jun 13, 2022 14:49 |
Jun 13, 2022 14:49 |
|
Page: Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)
|
|
PNG File nctn logo.png |
34 kB |
Geri Blake |
Jun 09, 2022 14:09 |
Jun 09, 2022 14:09 |
|
Page: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis (A091105)
|
|
PNG File classic directory name.png |
74 kB |
Justin Kirby |
Jun 08, 2022 08:12 |
Jun 08, 2022 08:12 |
|
Page: I-SPY 2 Breast Dynamic Contrast Enhanced MRI Trial (ISPY2)
|
|
Microsoft Excel Spreadsheet Multi-feature MRI NACT Data.xlsx |
130 kB |
Geri Blake |
Jun 08, 2022 06:49 |
Jun 08, 2022 06:49 |
|
Page: I-SPY 2 Breast Dynamic Contrast Enhanced MRI Trial (ISPY2)
|
|
File TCIA_FDG-PET-CT-Lesions_v1.tcia |
193 kB |
Tracy Nolan |
Jun 02, 2022 11:30 |
Jun 02, 2022 11:30 |
|
Page: A whole-body FDG-PET/CT dataset with manually annotated tumor lesions (FDG-PET-CT-Lesions)
|
|
File manifest_FDG-PET-CT-Lesions_v1.csv |
735 kB |
Tracy Nolan |
Jun 02, 2022 11:27 |
Jun 02, 2022 11:27 |
|
Page: A whole-body FDG-PET/CT dataset with manually annotated tumor lesions (FDG-PET-CT-Lesions)
|
|
File AHOD0831 manifest June 2022.tcia |
512 kB |
Geri Blake |
May 31, 2022 08:40 |
May 31, 2022 08:40 |
|
Page: Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma (AHOD0831)
|
|
File Clinical Metadata FDG PET_CT Lesions.csv |
1.34 MB |
Tracy Nolan |
May 25, 2022 21:38 |
May 25, 2022 21:38 |
|
Page: A whole-body FDG-PET/CT dataset with manually annotated tumor lesions (FDG-PET-CT-Lesions)
|
|
File UCSF-PDGM-metadata.csv |
50 kB |
Tracy Nolan |
May 20, 2022 14:17 |
May 20, 2022 14:17 |
|
Page: The University of California San Francisco Preoperative Diffuse Glioma MRI (UCSF-PDGM)
|
|
PDF File TCIA License for Limited Access Collections w-NC (… |
471 kB |
Kirk Smith |
May 19, 2022 14:10 |
May 19, 2022 14:10 |
|
Page: HEAD-NECK-RADIOMICS-HN1
|
|
PDF File TCIA Restricted License 20220519.pdf |
247 kB |
Kirk Smith |
May 19, 2022 08:01 |
May 19, 2022 08:01 |
|
Page: Data Usage Policies and Restrictions
|
|
PDF File TCIA Restricted License 20220325.pdf |
186 kB |
Kirk Smith |
May 18, 2022 21:53 |
May 18, 2022 21:53 |
|
Page: Data Usage Policies and Restrictions
|
|
PNG File dlbcl-morph layout.png |
43 kB |
Justin Kirby |
May 16, 2022 15:37 |
May 16, 2022 15:37 |
|
Page: H&E and immunohistochemical stain images of 209 cases of diffuse large B-cell lymphoma linked with cytogenetic features and clinical outcomes (DLBCL-Morphology)
|
|
File column_description.csv |
3 kB |
Justin Kirby |
May 16, 2022 15:31 |
May 16, 2022 15:31 |
|
Page: H&E and immunohistochemical stain images of 209 cases of diffuse large B-cell lymphoma linked with cytogenetic features and clinical outcomes (DLBCL-Morphology)
|
|
PNG File her2-roi.png |
1.16 MB |
Justin Kirby |
May 09, 2022 12:20 |
May 09, 2022 12:20 |
|
Page: HER2 and trastuzumab treatment response H&E slides with tumor ROI annotations (HER2 tumor ROIs)
|
